Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis : Successful Management With Abrocitinib
(2026) In Pediatric Dermatology- Abstract
Psoriasiform eruptions have been described in patients treated with dupilumab. This case report describes an adolescent with severe atopic dermatitis who developed a widespread psoriasiform dermatitis 8 months after starting dupilumab. His therapy was switched to abrocitinib resulting in near-complete resolution of the psoriatic lesions with good atopic dermatitis control. This case adds to the limited pediatric literature on dupilumab-induced psoriasis and highlights abrocitinib as an effective therapeutic alternative capable of addressing both conditions concurrently.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/c220fc2c-e69d-4eb5-bcb3-8fe7115d6f79
- author
- Theodosiou, Grigorios
LU
and Svensson, Åke
LU
- organization
- publishing date
- 2026
- type
- Contribution to journal
- publication status
- epub
- subject
- in
- Pediatric Dermatology
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- pmid:42152691
- scopus:105039040651
- ISSN
- 0736-8046
- DOI
- 10.1111/pde.70269
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2026 The Author(s). Pediatric Dermatology published by Wiley Periodicals LLC.
- id
- c220fc2c-e69d-4eb5-bcb3-8fe7115d6f79
- date added to LUP
- 2026-07-14 15:37:19
- date last changed
- 2026-07-28 17:20:08
@article{c220fc2c-e69d-4eb5-bcb3-8fe7115d6f79,
abstract = {{<p>Psoriasiform eruptions have been described in patients treated with dupilumab. This case report describes an adolescent with severe atopic dermatitis who developed a widespread psoriasiform dermatitis 8 months after starting dupilumab. His therapy was switched to abrocitinib resulting in near-complete resolution of the psoriatic lesions with good atopic dermatitis control. This case adds to the limited pediatric literature on dupilumab-induced psoriasis and highlights abrocitinib as an effective therapeutic alternative capable of addressing both conditions concurrently.</p>}},
author = {{Theodosiou, Grigorios and Svensson, Åke}},
issn = {{0736-8046}},
language = {{eng}},
publisher = {{John Wiley & Sons Inc.}},
series = {{Pediatric Dermatology}},
title = {{Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis : Successful Management With Abrocitinib}},
url = {{http://dx.doi.org/10.1111/pde.70269}},
doi = {{10.1111/pde.70269}},
year = {{2026}},
}